Evidence map›Paper›PMID 11522606›Full record

ArticleBritish journal of pharmacology2001

[125I-His(9)]-ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue: up-regulation of receptors with athersclerosis.

S D Katugampola, Z Pallikaros, A P Davenport

Open access · bronzeAbstract read
In one paragraph

Article in British journal of pharmacology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 190 citations in OpenAlex.

  1. Acute peripheral metabolic effects of intraarterial ghrelin infusion in healthy young men.The Journal of clinical endocrinology and metabolism · 2011
    Trial
  2. Article
  3. Article
  4. Review
  5. Observational
  6. Article
  7. Review
  8. Article
  9. Review
  10. Physiological significance of ghrelin in the cardiovascular system.Proceedings of the Japan Academy. Series B, Physical and biological sciences · 2019
    Review
  11. Review
  12. The CD36-PPARγ Pathway in Metabolic Disorders.International journal of molecular sciences · 2018
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Effect of ghrelin on inflammatory response in lung contusion.The Kaohsiung journal of medical sciences · 2013
    Article
  19. AMPK activity is down-regulated in endothelial cells of GHS-R(-/-) mice.International journal of clinical and experimental pathology · 2013
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

S D KatugampolaClinical Pharmacology Unit, University of Cambridge, Level 6, Centre for Clinical Investigation, Box 110, Addenbrooke's Hospital, Cambridge, CB2 2QQ, UK. sdk23@hermes.cam.ac.uk
Z Pallikaros
A P Davenport
Addenbrooke's Hospital · GBAmersham Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

1. Ghrelin is the recently identified endogenous ligand for the cloned growth hormone secretagogue receptor (GHS-R). We have characterized for the first time the binding of human [125I-His(9)]-ghrelin to normal human and rat tissue and demonstrated expression of this 'orphan' receptor that has previously been predicted to exist from mRNA. Furthermore, we have discovered that [125I-His(9)]-ghrelin density is significantly increased in atherosclerosis. 2. [125I-His(9)]-Ghrelin bound to non-diseased human heart (left ventricle) with an association rate constant (k(obs)) of 0.16+/-0.004 min(-1), a dissociation rate constant of 0.068+/-0.0005 min(-1) (kinetically derived K(D) of 0.1 nM; n=5 individuals+/-s.e.mean), a K(D) of 0.43+/-0.08 nM and B(max) of 7.8+/-0.9 fmol mg(-1) protein (n=6 individual+/-s.e.mean). 3. Specific [125I-His(9)]-ghrelin binding was to the human vasculature including aorta, coronary, pulmonary, arcuate arteries in the kidney and saphenous veins. In rat tissues, binding sites were also localized to the vasculature in peripheral tissues as well as the granular layer of the cerebellum in the CNS. 4. [125I-His(9)]-Ghrelin binding was significantly up-regulated (3 - 4 fold) in both atherosclerotic coronary arteries and saphenous vein grafts with advanced intimal thickening, compared with normal vessels (P<0.05). 5. Our results suggest that the native receptor for [125I-His(9)]-ghrelin may be widely distributed in the human cardiovascular system. Furthermore, changes in the density of this proposed ghrelin receptor implicates this new transmitter system in the development of atherosclerosis and may therefore represent a novel therapeutic target in the treatment of cardiovascular disease.

Indexed as

Peptide HormonesReceptors, G-Protein-CoupledAdultAgedAmino Acid SequenceAnimalsArteriosclerosisAutoradiographyBinding, CompetitiveGhrelinHumansHydrogen-Ion ConcentrationIodine RadioisotopesKineticsMiddle AgedMolecular Sequence DataGhrelinIodine RadioisotopesPeptide HormonesPeptidesReceptors, Cell SurfaceReceptors, GhrelinReceptors, G-Protein-Coupled

Identifiers

PMID11522606
PMCPMC1572927
OpenAlexW2031481579

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.